The Patent Finder

LipoScience, Inc.

8 patents currently held · Updated Nov 18, 2026
25 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

2
Ending by 2030
Mar 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 10, 2027
    The maintenance fee for NMR Quantification of TMAO (US 11,782,002) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
  • 1 fee due Jun 10, 2027
    The maintenance fee for Methods, systems and computer programs for assessing CHD risk using adjusted HDL article number measurements (US 10,504,610) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
  • 1 fee due Sep 26, 2027
    The maintenance fee for Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements (US 11,942,187) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.
  • 1 fee due Oct 7, 2027
    The maintenance fee for NMR Quantification of Tmao (US 10,613,044) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

PatentTitleStatus Expires Confidence
US 10,504,610Methods, systems and computer programs for assessing CHD risk using adjusted HDL article number measurements
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,942,187Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,782,002NMR Quantification of TMAO
In force
 · Medium confidence
In forceMedium confidence
US 11,990,243Multiple-marker risk parameters predictive of conversion to diabetes
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,613,044NMR Quantification of Tmao
In force
 · Medium confidence
In forceMedium confidence
US 11,124,837Methods and systems for predicting colorectal cancer incidence and mortality
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,467,171Methods and Systems to Detect and Quantify the Amount of LP-X and Other Abnormal Lipoproteins in a Biosample Using NMR Spectroscopy
In force
 · High confidence
In forceHigh confidence
US 12,359,330Molten oxide electrolysis methods and related systems
In force
 · From the USPTO record
In forceFrom the USPTO record
Also on record, not counted in the 8: 25 patents in force now held by others · 4 lapsed for an unpaid fee · 9 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 1 abandoned · 3 no status recorded

Showing 1 to 10 of 10, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/890,018Multi-Parameter Metabolic Vulnerability Index EvaluationsSep 19, 2024Pending
18/661,491May 10, 2024No status recorded
18/661,461Multiple-Marker Risk Parameters Predictive of Conversion to DiabetesMay 10, 2024Pending
18/598,979Mar 7, 2024No status recorded
18/471,903NMR Quantification of TMAOSep 21, 2023Pending
18/366,599Metabolic Vulnerability Analyzed by NMRAug 7, 2023Pending
18/210,959Multi-Parameter Diabetes Risk EvaluationsJun 16, 2023Pending
17/508,214Oct 22, 2021No status recorded
17/291,723Methods to Predict Liver Disease Mortality Using Lipoprotein Lp-ZNov 7, 2019Pending
15/629,926Quantitative NMR Clinical Analyzers With Automatic NMR Temperature Sensitivity Compensation that Accommodate Large Ambient Operational Temperature RangesJun 22, 2017Abandoned
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited